What is the place of linezolid in the treatment of methicillin-resistant Staphylococcus aureus nosocomial pneumonia and complicated skin and soft tissue infections in Europe?

Clin Microbiol Infect. 2014 Apr:20 Suppl 4:1-2. doi: 10.1111/1469-0691.12496.

Authors

O Dumitrescu¹, G Lina

Affiliation

¹ CIRI, Université Lyon1, Inserm U1111, CNRS UMR5308, Ecole Normale Supérieure de Lyon, Centre National de Référence des Staphylocoques, Hospices Civils de Lyon, Lyon, France.

PMID: 24580737
DOI: 10.1111/1469-0691.12496

No abstract available

Publication types

Editorial
Introductory Journal Article

MeSH terms

Acetamides / therapeutic use*
Anti-Bacterial Agents / therapeutic use*
Cross Infection / drug therapy
Europe
Humans
Linezolid
Methicillin-Resistant Staphylococcus aureus*
Oxazolidinones / therapeutic use*
Pneumonia, Staphylococcal / drug therapy*
Pneumonia, Staphylococcal / microbiology
Soft Tissue Infections / drug therapy*
Soft Tissue Infections / microbiology
Staphylococcal Skin Infections / drug therapy*
Staphylococcal Skin Infections / microbiology

Substances

Acetamides
Anti-Bacterial Agents
Oxazolidinones
Linezolid